Brivudine
5-[(E)-2-bromoethenyl]-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
Molecular Identity
Brivudine
5-[(E)-2-bromoethenyl]-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
PubChem CID: 446727
2D Structure
Properties
C11H13BrN2O5
Molecular Formula
333.13
Molecular Weight
g/mol
332.0008
Exact Mass
Da
-0.4
XLogP
Drug-like (Lipinski: < 5)
99.1
TPSA
Good oral absorption (< 140 A²)
3
H-Bond Donors
5
H-Bond Acceptors
450
Complexity
SMILES
Canonical SMILES
SMILES: C1C(C(OC1N2C=C(C(=O)NC2=O)C=CBr)CO)OIsomeric SMILES
SMILES: C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)/C=C/Br)CO)OSynonyms(20)
Brivudine69304-47-8BVDU(E)-5-(2-Bromovinyl)-2'-deoxyuridineBrivudinHelpinZostexBrivudinaBrivudinumRP101(E)-5-(2-Bromovinyl)-deoxyuridineRP-101DTXSID0045755trans-5-(2-Bromovinyl)-2'-deoxyuridineNSC-633770
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Brivudine
Loading drug network...